Y Intercept Hong Kong Ltd Has $660,000 Stake in Blue Owl Capital Inc. $OWL

Y Intercept Hong Kong Ltd reduced its position in Blue Owl Capital Inc. (NYSE:OWL) by 81.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 72,262 shares of the company’s stock after selling 319,064 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Blue Owl Capital were worth $660,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of OWL. Arax Advisory Partners bought a new stake in Blue Owl Capital during the 4th quarter valued at $25,000. Roxbury Financial LLC lifted its stake in shares of Blue Owl Capital by 383.6% in the fourth quarter. Roxbury Financial LLC now owns 1,765 shares of the company’s stock valued at $26,000 after buying an additional 1,400 shares in the last quarter. Toronto Dominion Bank acquired a new position in shares of Blue Owl Capital during the fourth quarter valued at about $26,000. Lavaca Capital LLC acquired a new position in shares of Blue Owl Capital during the fourth quarter valued at about $28,000. Finally, Halbert Hargrove Global Advisors LLC increased its position in shares of Blue Owl Capital by 83.5% during the fourth quarter. Halbert Hargrove Global Advisors LLC now owns 2,000 shares of the company’s stock worth $30,000 after acquiring an additional 910 shares in the last quarter. Institutional investors and hedge funds own 35.85% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on OWL. Citizens Jmp lowered their target price on shares of Blue Owl Capital from $21.00 to $17.00 and set a “market outperform” rating on the stock in a report on Thursday, July 9th. TD Cowen reissued a “buy” rating and set a $14.00 price objective on shares of Blue Owl Capital in a report on Monday, May 18th. Citigroup reissued a “market outperform” rating on shares of Blue Owl Capital in a research note on Thursday. Capital One Financial set a $11.00 target price on Blue Owl Capital in a report on Monday. Finally, UBS Group reiterated a “neutral” rating and set a $9.50 price target on shares of Blue Owl Capital in a report on Thursday, June 11th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $13.22.

Blue Owl Capital Stock Down 0.7%

Blue Owl Capital stock opened at $9.29 on Tuesday. Blue Owl Capital Inc. has a 52 week low of $7.95 and a 52 week high of $21.08. The company’s 50 day moving average price is $9.62 and its two-hundred day moving average price is $10.92. The stock has a market cap of $14.45 billion, a P/E ratio of 77.44, a P/E/G ratio of 1.01 and a beta of 1.22.

Blue Owl Capital (NYSE:OWL) last released its earnings results on Thursday, April 30th. The company reported $0.19 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.19. The company had revenue of $699.88 million during the quarter, compared to analyst estimates of $687.23 million. Blue Owl Capital had a return on equity of 21.97% and a net margin of 2.96%. On average, equities analysts anticipate that Blue Owl Capital Inc. will post 0.87 EPS for the current year.

Blue Owl Capital Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were given a $0.23 dividend. This is an increase from Blue Owl Capital’s previous quarterly dividend of $0.23. This represents a $0.92 annualized dividend and a yield of 9.9%. The ex-dividend date of this dividend was Wednesday, May 13th. Blue Owl Capital’s payout ratio is presently 766.67%.

Blue Owl Capital Profile

Blue Owl Capital is a global alternative asset manager that focuses on private credit, direct lending and equity-related strategies for institutional investors. Headquartered in New York, the firm develops and manages a range of private markets products designed to provide capital solutions to middle-market and larger corporate borrowers, as well as liquidity and partnership arrangements with private equity firms and other alternative managers.

Its core activities include direct lending and credit strategies that provide senior, unitranche and other structured loan products to companies across industries.